Characteristic | Patient no. | Mean ± SD | ||||||||
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ||
Age (y) | 66 | 69 | 76 | 70 | 75 | 67 | 65 | 73 | 69 | 70 ± 4 |
TBF K1-15O-H2O (mL/min/mL) | 0.08 | 0.22 | 0.29 | 0.10 | 0.18 | 0.08 | 0.14 | 0.54 | 0.55 | 0.24 ± 0.18 |
TBF K1-82Rb (mL/min/mL) | 0.08 | * | 0.28 | 0.11 | 0.16 | 0.08 | 0.19 | 0.35 | 0.30 | 0.19 ± 0.10 |
TBF 60% threshold (82Rb SUVmean) | 2.07 | 1.97 | 4.11 | 0.95 | 3.81 | 1.09 | 2.26 | 3.88 | 3.49 | 2.63 ± 1.22 |
TBF MRI guided (82Rb SUVmean) | 0.92 | 0.93 | 2.96 | 0.87 | 2.44 | 1.28 | 2.07 | 3.38 | 2.56 | 1.93 ± 0.96 |
PI-RADS | 4 | 4 | 5 | 4 | 4 | 4 | 5 | 5 | 5 | 4.4 ± 0.53 |
GGG (postprostatectomy) | 1 | 2 | 4 | 2 | 5 | 1 | 2 | 4 | 5 | 2.9 ± 1.6 |
PSA (ng/mL) | 4.7 | 11.2 | 16.8 | 3.9 | 14.1 | 3 | 7.9 | 26.7 | 17.6 | 11.7 ± 7.8 |
Prostate volume (MRI) (cm3) | 66 | 71 | 47 | 35 | 105 | 51 | 42 | 41 | 73 | 59 ± 22.1 |
↵* Value missing because of irregularity in 82Rb infusion.